ExcelMale
Menu
Home
What's new
Latest activity
Forums
New posts
Search forums
What's new
New posts
Latest activity
Videos
Lab Tests
Doctor Finder
Buy Books
About Us
Men’s Health Coaching
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Navigation
Install the app
Install
More options
Contact us
Close Menu
Forums
Testosterone Replacement, Low T, HCG, & Beyond
Blood Test Discussion
Understanding My Levels
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="Systemlord" data-source="post: 241196" data-attributes="member: 15832"><p><h3>Differential effects of 11 years of long-term injectable testosterone undecanoate therapy on anthropometric and metabolic parameters in hypogonadal men with normal weight, overweight and obesity in comparison with untreated controls: real-world data from a controlled registry study</h3><h3>Results</h3><p>Long-term TTh in hypogonadal men, irrespective of weight at baseline, produced improvements in body weight, waist circumference (WC) and body mass index (BMI). Furthermore, TTh decreased fasting blood glucose and HbA1c and improved lipid profiles. Gradual decreases in blood pressure (systolic and diastolic) and pulse pressure occurred in men treated with T in each group. <strong>Marked reductions in mortality and major cardiovascular events were recorded in men receiving TTh.</strong></p><p></p><h3>Conclusions</h3><p>Our findings demonstrate that TTh produces reductions in weight, WC, and BMI. <strong>There were 77 (19.5%) deaths in the untreated groups and 23 (5.4%) in the T-groups. </strong>Based on these findings we suggest that long-term TTh in overweight and obese hypogonadal men produces progressive and sustained clinically meaningful weight loss and that <strong>TTh may contribute to reductions</strong></p><p> <strong>in mortality and incident major adverse cardiovascular events.</strong></p><p></p><p>[URL unfurl="true"]https://www.nature.com/articles/s41366-019-0517-7[/URL]</p></blockquote><p></p>
[QUOTE="Systemlord, post: 241196, member: 15832"] [HEADING=2]Differential effects of 11 years of long-term injectable testosterone undecanoate therapy on anthropometric and metabolic parameters in hypogonadal men with normal weight, overweight and obesity in comparison with untreated controls: real-world data from a controlled registry study[/HEADING] [HEADING=2]Results[/HEADING] Long-term TTh in hypogonadal men, irrespective of weight at baseline, produced improvements in body weight, waist circumference (WC) and body mass index (BMI). Furthermore, TTh decreased fasting blood glucose and HbA1c and improved lipid profiles. Gradual decreases in blood pressure (systolic and diastolic) and pulse pressure occurred in men treated with T in each group. [B]Marked reductions in mortality and major cardiovascular events were recorded in men receiving TTh.[/B] [HEADING=2]Conclusions[/HEADING] Our findings demonstrate that TTh produces reductions in weight, WC, and BMI. [B]There were 77 (19.5%) deaths in the untreated groups and 23 (5.4%) in the T-groups. [/B]Based on these findings we suggest that long-term TTh in overweight and obese hypogonadal men produces progressive and sustained clinically meaningful weight loss and that [B]TTh may contribute to reductions in mortality and incident major adverse cardiovascular events.[/B] [URL unfurl="true"]https://www.nature.com/articles/s41366-019-0517-7[/URL] [/QUOTE]
Insert quotes…
Verification
Post reply
Share this page
Facebook
Twitter
Reddit
Pinterest
Tumblr
WhatsApp
Email
Share
Link
Sponsors
Forums
Testosterone Replacement, Low T, HCG, & Beyond
Blood Test Discussion
Understanding My Levels
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
Accept
Learn more…
Top